设为首页 加入收藏

TOP

KADCYLA (trastuzumab emtansine) injection(十九)
2013-09-23 15:29:31 来源: 作者: 【 】 浏览:10273次 评论:0

Rx only

1 vial
 
Genentech

10135258

PRINCIPAL DISPLAY PANEL - 160 mg Vial Label

NDC 50242-087-01
 
Kadcyla™
(ado-trastuzumab
emtansine)
For Injection
 
160 mg per vial

For Intravenous Infusion Only
Reconstitute and Dilute prior
to administration
Single-Dose Vial –
Discard Unused Portion

KEEP REFRIGERATED

Rx only

1 vial
 
Genentech

4862100

KADCYLA
trastuzumab emtansine injection, powder, lyophilized, for solution

Product Information

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Item Code (Source)

NDC:50242-088

Route of Administration

INTRAVENOUS

DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name

Basis of Strength

Strength

TRASTUZUMAB EMTANSINE (TRASTUZUMAB EMTANSINE)

TRASTUZUMAB EMTANSINE

20 mg  in 1 mL

Inactive Ingredients

Ingredient Name

Strength

SUCROSE

60 mg  in 1 mL

SUCCINIC ACID

1.18 mg  in 1 mL

SODIUM HYDROXIDE

0.45 mg  in 1 mL

POLYSORBATE 20

0.2 mg  in 1 mL

WATER

Packaging

Item Code

Package Description
1
NDC:50242-088-01

1 in 1 CARTON

1
5 mL in 1 VIAL, SINGLE-USE

Marketing Information

Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date

BLA

BLA125427

02/22/2013
KADCYLA
trastuzumab emtansine injection, powder, lyophilized, for solution
Product Information
Product Type

HUMAN PRESCRIPTION DRUG LABEL

Item Code (Source)

NDC:50242-087

Route of Administration

INTRAVENOUS

DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name

Basis of Strength

Strength

TRASTUZUMAB EMTANSINE (TRASTUZUMAB EMTANSINE)

TRASTUZUMAB EMTANSINE

20 mg  in 1 mL

Inactive Ingredients

Ingredient Name

Strength

SUCROSE

60 mg  in 1 mL

SUCCINIC ACID

1.18 mg  in 1 mL

SODIUM HYDROXIDE

0.45 mg  in 1 mL

POLYSORBATE 20

0.2 mg  in 1 mL

WATER

Packaging

Item Code

Package Description

1

NDC:50242-087-01

1 in 1 CARTON

1

8 mL in 1 VIAL, SINGLE-USE

Marketing Information

Marketing Category

Application Number or Monograph Citation

Marketing Start Date

Marketing End Date
 
BLA

BLA125427

02/22/2013

Labeler - Genentech, Inc. (080129000)

Establishment

Name

Address

ID/FEI

Business Operations

Genentech, Inc. (Hillsboro)


833220176

LABEL(50242-088, 50242-087), PACK(50242-088, 50242-087)

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 16 17 18 19 下一页 尾页 19/19/19
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Kadcyla 下一篇Herceptin (trastuzumab)

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位